Yahoo
NasdaqGM - Delayed Quote USD

Protagonist Therapeutics, Inc. (PTGX)

145.72 -3.08 (-2.07%)
At close: September 4 at 4:00:00 PM EDT
145.00 -0.72 (-0.49%)
After hours: September 4 at 7:30:03 PM EDT
Trade PTGX on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
281,992
46,016
434,433
60,000
26,581
Operating Expense
223,650
204,143
181,590
153,652
157,954
Operating Income
58,342
-158,127
252,843
-93,652
-131,373
Net Non Operating Interest Income Expense
26,115
28,789
26,315
14,898
4,060
Other Income Expense
-119
27
250
-201
-80
Pretax Income
84,338
-129,311
279,408
-78,955
-127,393
Tax Provision
1,429
838
4,220
0
0
Net Income Common Stockholders
82,909
-130,149
275,188
-78,955
-127,393
Diluted NI Available to Com Stockholders
82,909
-130,149
275,188
-78,955
-127,393
Basic EPS
1.22
-2.05
4.47
-1.39
-2.60
Diluted EPS
1.03
-2.05
4.23
-1.39
-2.60
Basic Average Shares
64,710.78
63,573.05
61,566.99
56,763.56
49,042.23
Diluted Average Shares
67,363.07
63,573.05
65,077.72
56,763.56
49,042.23
Total Operating Income as Reported
58,342
-158,127
252,843
-93,652
-131,373
Total Expenses
223,650
204,143
181,590
153,652
157,954
Net Income from Continuing & Discontinued Operation
82,909
-130,149
275,188
-78,955
-127,393
Normalized Income
82,909
-130,149
275,188
-78,955
-127,393
Interest Income
26,115
28,789
26,315
14,898
4,060
Interest Expense
--
--
--
--
0
Net Interest Income
26,115
28,789
26,315
14,898
4,060
EBIT
58,342
-158,127
252,843
-93,652
-131,373
EBITDA
59,883
-156,847
253,669
-92,675
-130,339
Reconciled Depreciation
1,541
1,280
826
977
1,034
Net Income from Continuing Operation Net Minority Interest
82,909
-130,149
275,188
-78,955
-127,393
Total Unusual Items Excluding Goodwill
0
--
--
--
0
Total Unusual Items
0
--
--
--
0
Normalized EBITDA
59,883
-156,847
253,669
-92,675
-130,339
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 8/11/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: